Medical Device Vigilance and Patient Safety Software Market Size to Hit USD 4.23 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Device Vigilance and Patient Safety Software Market

5.1. COVID-19 Landscape: Medical Device Vigilance and Patient Safety Software Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Device Vigilance and Patient Safety Software Market, By Software Type

8.1. Medical Device Vigilance and Patient Safety Software Market, by Software Type

8.1.1 Adverse Event Reporting Software

8.1.1.1. Market Revenue and Forecast

8.1.2. Risk Management Software

8.1.2.1. Market Revenue and Forecast

8.1.3. Regulatory Compliance Management Software

8.1.3.1. Market Revenue and Forecast

8.1.4. Incident Management and Investigation Software

8.1.4.1. Market Revenue and Forecast

8.1.5. Post-Market Surveillance Software

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Medical Device Vigilance and Patient Safety Software Market, By Deployment Mode

9.1. Medical Device Vigilance and Patient Safety Software Market, by Deployment Mode

9.1.1. Cloud-based Software

9.1.1.1. Market Revenue and Forecast

9.1.2. On-premise Software

9.1.2.1. Market Revenue and Forecast

9.1.3. Hybrid Software

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Medical Device Vigilance and Patient Safety Software Market, By End-Use

10.1. Medical Device Vigilance and Patient Safety Software Market, by End-Use

10.1.1. Medical Device Manufacturers

10.1.1.1. Market Revenue and Forecast

10.1.2. Contract Research Organizations (CROs)

10.1.2.1. Market Revenue and Forecast

10.1.3. Regulatory Authorities

10.1.3.1. Market Revenue and Forecast

10.1.4. Hospitals and Healthcare Provider

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Medical Device Vigilance and Patient Safety Software Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Software Type

11.1.2. Market Revenue and Forecast, by Deployment Mode

11.1.3. Market Revenue and Forecast, by End-Use

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Software Type

11.1.4.2. Market Revenue and Forecast, by Deployment Mode

11.1.4.3. Market Revenue and Forecast, by End-Use

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Software Type

11.1.5.2. Market Revenue and Forecast, by Deployment Mode

11.1.5.3. Market Revenue and Forecast, by End-Use

11.2. Europe

11.2.1. Market Revenue and Forecast, by Software Type

11.2.2. Market Revenue and Forecast, by Deployment Mode

11.2.3. Market Revenue and Forecast, by End-Use

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Software Type

11.2.4.2. Market Revenue and Forecast, by Deployment Mode

11.2.4.3. Market Revenue and Forecast, by End-Use

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Software Type

11.2.5.2. Market Revenue and Forecast, by Deployment Mode

11.2.5.3. Market Revenue and Forecast, by End-Use

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Software Type

11.2.6.2. Market Revenue and Forecast, by Deployment Mode

11.2.6.3. Market Revenue and Forecast, by End-Use

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Software Type

11.2.7.2. Market Revenue and Forecast, by Deployment Mode

11.2.7.3. Market Revenue and Forecast, by End-Use

11.3. APAC

11.3.1. Market Revenue and Forecast, by Software Type

11.3.2. Market Revenue and Forecast, by Deployment Mode

11.3.3. Market Revenue and Forecast, by End-Use

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Software Type

11.3.4.2. Market Revenue and Forecast, by Deployment Mode

11.3.4.3. Market Revenue and Forecast, by End-Use

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Software Type

11.3.5.2. Market Revenue and Forecast, by Deployment Mode

11.3.5.3. Market Revenue and Forecast, by End-Use

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Software Type

11.3.6.2. Market Revenue and Forecast, by Deployment Mode

11.3.6.3. Market Revenue and Forecast, by End-Use

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Software Type

11.3.7.2. Market Revenue and Forecast, by Deployment Mode

11.3.7.3. Market Revenue and Forecast, by End-Use

11.4. MEA

11.4.1. Market Revenue and Forecast, by Software Type

11.4.2. Market Revenue and Forecast, by Deployment Mode

11.4.3. Market Revenue and Forecast, by End-Use

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Software Type

11.4.4.2. Market Revenue and Forecast, by Deployment Mode

11.4.4.3. Market Revenue and Forecast, by End-Use

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Software Type

11.4.5.2. Market Revenue and Forecast, by Deployment Mode

11.4.5.3. Market Revenue and Forecast, by End-Use

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Software Type

11.4.6.2. Market Revenue and Forecast, by Deployment Mode

11.4.6.3. Market Revenue and Forecast, by End-Use

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Software Type

11.4.7.2. Market Revenue and Forecast, by Deployment Mode

11.4.7.3. Market Revenue and Forecast, by End-Use

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Software Type

11.5.2. Market Revenue and Forecast, by Deployment Mode

11.5.3. Market Revenue and Forecast, by End-Use

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Software Type

11.5.4.2. Market Revenue and Forecast, by Deployment Mode

11.5.4.3. Market Revenue and Forecast, by End-Use

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Software Type

11.5.5.2. Market Revenue and Forecast, by Deployment Mode

11.5.5.3. Market Revenue and Forecast, by End-Use

Chapter 12. Company Profiles

12.1. Medtronic plc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Oracle Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Veeva Systems Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. IQVIA Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Siemens Healthineers

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AbbVie Inc. (Allergan)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. GE Healthcare

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Hill-Rom Holdings, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Becton, Dickinson and Company (BD)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Stryker Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The medical device vigilance and patient safety software market size is expected to increase from USD 1.40 billion in 2025 to USD 4.23 billion by 2035.

Answer : The medical device vigilance and patient safety software market is expected to grow at a compound annual growth rate (CAGR) of around 11.70% from 2026 to 2035.

Answer : The major players in the medical device vigilance and patient safety software market include Medtronic plc, Oracle Corporation, Veeva Systems Inc., IQVIA Inc., Siemens Healthineers, AbbVie Inc. (Allergan), GE Healthcare, Hill-Rom Holdings, Inc., Becton, Dickinson and Company (BD), Stryker Corporation, Bio-Rad Laboratories, Inc., Wolters Kluwer N.V., Pharmaceutical Product Development (PPD), Veristat, LLC, and PRA Health Sciences, Inc.

Answer : The driving factors of the medical device vigilance and patient safety software market are the increasing regulatory compliance requirements, rising focus on patient safety, and the growing need for real-time monitoring and reporting of medical device-related adverse events.

Answer : North America region will lead the global medical device vigilance and patient safety software market during the forecast period 2026 to 2035.